ULBP2 and breast cancer: High expression of miR-519a-3p in breast cancer was shown to not only induce the expression of TRAIL and FasL to increase the apoptosis resistance of tumor cells, but also reduced the sensitivity of tumor cells to NK cells by downregulating the expression of the NKG2D ligands ULBP2 and MICA.